维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Vergote IB"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian caneer显示文摘	Vergote IB De Wever I Decloedt J	2000	Se- min Oncol2000，27，1：	1
2	Neoadjuvant chemother apy versus primary debulking surgery in advanced ovarian careino ma显示文摘	Vergote IB De Wever I DecloedtJ ct al	2000	Semin Oncol2000，27，37：	1
3	Cisplatin(P),vinblas-tine(V)and bleomycin(B)combination chemotherapy in recurrent or advanced granulose(-theca)cell tumors of the ovary:an EORTC Gynacological cancer cooperative group study显示文摘	Pecorelli S Wagenaar HC Vergote IB	1999	Eur J Cancer1999，35，9：	1
4	Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors显示文摘	Trop C Kaern J Vergote IB	1993	Gynecol Oncol1993，51，2：	1
5	Adenoma malignum (minimal deviation adenocarcinoma) of the cervix responsive to hormonal treatment显示文摘	Orye G Moerman P Vergote IB	1996	Inter J Gynecol Cancer1996，6，：	1
6	Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study 显示文摘	Vergote IB Jimeno A Joly F	2014	J Clin Oncol2014，32，4：	1
7	A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/ platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study 显示文摘	Hirte H Vergote IB Jeffrey JR	2006	Gynecol Oncol2006，102，：	1
8	Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer显示文摘	Vergote IB De Wever I Decloedt J	2000	Semin Oncol2000，27，37：	1
9	Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer 显示文摘	de Wever I Decloedt J	2000	Semin Oncol2000，27，37：	1
10	Randomized, phase II, pla- cebo-controlled, double-blind study with and without enzastaurin in combination with paclitaxel and carboplatin as first-line treatment followed by maintenance treatment in advanced ovarian cancer显示文摘	Vergote IB Chekerov R Amant F	2013	J Clin Oncol2013，31，25：	1
11	A case report of unusual complication of myomatous uterus in pregnancy:spontaneous perforation of myoma after red degeneration显示文摘	Makar AP Meulyzer PR Vergote IB	1989	Eur J Obstet Gynecol Reprod Biol1989，31，3：	1
12	Bleomycin-ifosfamide-cisplatinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma:a second look显示文摘	Ramm K Vergote IB Kaem J		0，，02：	1
13	Randomized multicenter phase Ⅱ trial comparing two schedules of etirinotecan pegol (NKTR 102) in women with recurrent platinum resistant/refractory epithelial ovarian cancer显示文摘	Vergote IB Garcia A Micha J	2013	J Clin Oncol2013，31，：	1
14	Neoadjuvant chemoth- er-apy versus primary debulking surgery in advanced ovarian carcino-ma显示文摘	Vergote IB De Wever I Decloedt J	2000	Semin Oncol2000，27，37：	1
15	A phase Ⅲ randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy:a National Cancer Institute of Canada Clinical Trials Group study显示文摘	Hirte H Vergote IB Jeffrey JR	2006	Gynecol Oncol2006，102，：	1
16	Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer显示文摘	Vergote IB De Wever I Decloedt J	2000	Semin Oncol2000，27，：	1
17	Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer 显示文摘	Vergote IB Declodet J	2001	Semin Oncol2001，27，1：	1
18	Neoadjuvant chemotherapy ver- sus primary debulking surgery in advanced ovarian cancer显示文摘	Vergote IB De Wever I Decloedt J	2000	Seminars in Oncology2000，27，37：	1
19	A phase Ⅲ randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group study 显示文摘	Hirte H Vergote IB Jeffrey JR	2006	Gynecol Oncol2006，102，2：	1
20	Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer显示文摘	Vergote IB De-Wever I Decloedt J	2000	Semin Oncol2000，27，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示